Anant Ramaswamy

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Anant Ramaswamy

Aug 26, 2024, 20:37 | Blog

Incredibly relevant study on immunotherapy in msi-h mCRC - Foxpaws Fauxpas

Foxpaws Fauxpas shared a post on X: "Fantastic and incredibly relevant study on immunorx in msi-h…

Aug 24, 2024, 08:15 | Blog

Aditya Dhanawat: ICIs in advanced gastric/gastroesophageal adenocarcinomas

Aditya Dhanawat shared on X: “Our use of ICIs (standard and alternative dosing) in advanced…

Aug 14, 2024, 07:33 | Insight

Olanzapine as antiemetic prophylaxis in chemotherapy

Elisa Agostinetto shared on X: "Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase…

Aug 13, 2024, 14:52 | Insight

5 articles suggested by Yüksel Ürün

Yüksel Ürün shared a few must-reads paper on X: 1. Molecularly guided therapy versus chemotherapy…

Jul 31, 2024, 08:54 | Blog

Akhil Kapoor: Intensifying Chemo in advanced Gastric Cancer doesn't improve survivals

Akhil Kapoor, Associate Professor and Medical Oncology at TMH Varanasi, shared a post on X about…

Jul 29, 2024, 23:25 | Insight

Akhil Kapoor: Intensifying Chemotherapy in advanced Gastric Cancer doesn't improve survivals

Akhil Kapoor, Associate Professor and Medical Oncology at TMH Varanasi, shared a post on X:…

Apr 22, 2024, 11:11 | Insight

New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy

Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…

All: 7 Posts: 1 - 100